These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 110506)

  • 1. Adenosine deaminase and nucleoside phosphorylase activity in patients with immunodeficiency syndromes.
    Chen SH; Ochs HD; Scott CR; Giblett ER
    Clin Immunol Immunopathol; 1979 Jun; 13(2):156-60. PubMed ID: 110506
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adenosine deaminase and nucleoside phosphorylase: a new approach to the etiopathogenesis of various immunologic deficiencies].
    Lucivero G; Dammacco F; Bonomo L
    Recenti Prog Med; 1977 Sep; 63(3):275-88. PubMed ID: 413174
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.
    Hirschhorn R
    Clin Immunol Immunopathol; 1986 Jul; 40(1):157-65. PubMed ID: 3087666
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
    Carson DA; Carrera CJ
    Semin Hematol; 1990 Jul; 27(3):260-9. PubMed ID: 2115692
    [No Abstract]   [Full Text] [Related]  

  • 6. Purine-nucleoside phosphorylase and adenosine amino-hydrolase activities in fibroblasts with the Lesch-Nyhan mutation.
    Barankiewicz J; Jezewska MM
    Adv Exp Med Biol; 1977; 76A():391-7. PubMed ID: 404851
    [No Abstract]   [Full Text] [Related]  

  • 7. An abnormal form of purine nucleoside phosphorylase in a family with a child with severe defective T-cell-and normal B-cell immunity.
    van Heukelom LH; Staal GE; Stoop JW; Zegers BJ
    Clin Chim Acta; 1976 Oct; 72(1):117-24. PubMed ID: 10103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleotide-metabolizing enzymes and lymphocyte differentiation.
    Barton RW; Goldschneider I
    Mol Cell Biochem; 1979 Dec; 28(1-3):135-47. PubMed ID: 231199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependency of adenosine deaminase and purine nucleoside phosphorylase activities in rat spleen and thymus.
    Peters GJ; Oosterhof A; Veerkamp JH
    Biol Neonate; 1982; 42(3-4):195-200. PubMed ID: 6814540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenosine deaminase and purine nucleoside phosphorylase activities during culturing of fibrolasts.
    Uitendaal MP; Oerlemans FT; de Bruyn CH; Oei TL; Hösli P
    Adv Exp Med Biol; 1980; 122A():415-20. PubMed ID: 6775503
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine deaminase and purine nucleoside phosphorylase activity in spleen cells of aged mice.
    Scholar EM; Rashidian M; Heidrick ML
    Mech Ageing Dev; 1980 Apr; 12(4):323-9. PubMed ID: 6771472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Aug; 35(8):2564-80. PubMed ID: 411964
    [No Abstract]   [Full Text] [Related]  

  • 16. [RNA degradation enzymes and purine nucleosides in the lymphocytes of patients with multiple sclerosis].
    Procházková L; Rendeková V; Pechán I
    Cesk Neurol Neurochir; 1987 Nov; 50(6):380-5. PubMed ID: 3123077
    [No Abstract]   [Full Text] [Related]  

  • 17. A micromethod for determining adenosine deaminase and purine nucleoside phosphorylase activity in cells from human peripheral blood.
    van der Weyden MB; Bailey L
    Clin Chim Acta; 1978 Jan; 82(1-2):179-84. PubMed ID: 412622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of purine nucleosides by mitochondrial enzymes of bovine liver.
    Lewis RA; Link L; Chen W
    Adv Exp Med Biol; 1989; 253A():353-7. PubMed ID: 2516408
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.
    Seegmiller JE
    Monogr Hum Genet; 1978; 10():88-91. PubMed ID: 102926
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.